// #pharmaceutical
2 articles
Novo Nordisk Discloses Breach of Clinical Trial Participant Data — Ozempic and GLP-1 Research Records Exposed
Danish pharmaceutical giant Novo Nordisk has disclosed a cybersecurity incident in which attackers gained unauthorised access to IT systems holding personal data of clinical trial participants, including individuals enrolled in GLP-1 receptor agonist trials for Ozempic and Wegovy. The breach raises significant regulatory concerns under EU clinical trial data protection requirements and the ICH GCP framework governing trial participant data handling.
West Pharmaceutical Services Files SEC 8-K After Ransomware Encrypts Systems and Exfiltrates Manufacturing Data
West Pharmaceutical Services, an S&P 500 drug delivery component manufacturer, disclosed a ransomware attack via SEC Form 8-K, confirming system encryption and data exfiltration affecting its manufacturing and quality systems. The incident highlights regulatory obligations for publicly listed companies to disclose material cybersecurity incidents and the specific risks facing pharmaceutical supply chain manufacturers.